- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05220475
A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent
January 27, 2022 updated by: Sang Hyub Lee, Seoul National University Hospital
A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent: Prospective Randomized Multicenter Study
Multi-center, randomized controlled study fc-SEMS with anchoring plastic stent vs uc-SEMS in malignant biliary obstruction
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study is multi-center, randomized controlled study to compare the stent patency in malignant biliary obstruction.
The patency of fully covered self expandable metal stent with external anchoring plastic stent was compared with that of uncovered self expandable metal stent.
Study Type
Interventional
Enrollment (Anticipated)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Recruiting
- Seoul National University Hospital
-
Contact:
- Sang Hyub Lee, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults with 19 years of age or older
- Those who voluntarily consented to the trial and signed a written consent
- Inoperable malignant biliary obstruction
Exclusion Criteria:
- Previous surgical biliary drainage
- Patients continuosly requiring percutaneous transhepatic biliary drainage
- History of biliary drainage with metal stent
- Biliary obstruction located in hilum or intrahepatic duct
- Patients with life expectancy of 3 months or less
- On pregnancy
- Unable to underwent endoscopic procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: fc-SEMS with anchoring plastic stent
fully covered self-expanable metal stent with an external anchoring plastic stent
|
Extrahepatic malignant biliary obstruction treated with fully covered self-expandable metal stent with an anchoring plastic stent
|
Active Comparator: uc-SEMS
uncovered self-expandable metal stent
|
Extrahepatic malignant biliary obstruction treated with uncovered self-expandable metal stent without an anchoring plastic stent
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of patent stent
Time Frame: 1 year
|
The number of patient without stent dysfuction divided by total number of patients
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stent obstruction
Time Frame: 1 year
|
Suspected by jaundice (Total bilirubin > 2 upper normal limit) or radiologic finding of stent occlusion which is confirmed by ERCP
|
1 year
|
Stent migration
Time Frame: 1 year
|
Radiologic finding of migration through Abdomen X-ray or CT scan
|
1 year
|
Re-intervention
Time Frame: 1 year
|
Endoscopic retrograde biliary drainage or Percutaneous transhepatic biliary drainage
|
1 year
|
Adverse event
Time Frame: 1 year
|
acute cholangitis, acute cholecystitis, acute pancreatitis
|
1 year
|
Overall survival
Time Frame: 1 year
|
Timespan from the diagnosis to the death
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 25, 2021
Primary Completion (Anticipated)
October 24, 2023
Study Completion (Anticipated)
October 24, 2024
Study Registration Dates
First Submitted
January 4, 2022
First Submitted That Met QC Criteria
January 27, 2022
First Posted (Actual)
February 2, 2022
Study Record Updates
Last Update Posted (Actual)
February 2, 2022
Last Update Submitted That Met QC Criteria
January 27, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- H-2012-043-1179
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Biliary Obstruction
-
Chinese University of Hong KongNot yet recruiting
-
Zagazig UniversityRecruitingMalignant Biliary ObstructionEgypt
-
Mansoura UniversityRecruitingMalignant Biliary ObstructionEgypt
-
Tianjin Medical University Cancer Institute and...UnknownMalignant Biliary ObstructionChina
-
Chinese University of Hong KongRecruitingMalignant Biliary ObstructionHong Kong
-
University Hospitals Dorset NHS Foundation TrustThe Christie NHS Foundation TrustRecruitingMalignant Biliary ObstructionUnited Kingdom
-
First People's Hospital of HangzhouCompletedMalignant Biliary ObstructionChina
-
Yonsei UniversityCompletedMalignant Biliary ObstructionKorea, Republic of
-
Johns Hopkins UniversityMedical University of South Carolina; University of Colorado, Denver; All India... and other collaboratorsCompletedMalignant Distal Biliary ObstructionUnited States, India, Japan, Italy, Netherlands
-
Istituto Clinico Humanitas Mater DominiRecruitingDistal Malignant Biliary ObstructionItaly
Clinical Trials on fully covered self-expandable metal stent with an anchoring external plastic stent
-
AdventHealthCompletedPancreatic Collection | Infected Pancreatic Necrosis | Acute Pancreatic Fluid Collection | Pancreatic and Peripancreatic Necrosis | Symptomatic Pancreatic NecrosisUnited States
-
Indiana UniversityWithdrawn
-
Radboud University Medical CenterErasmus Medical CenterTerminatedOesophageal Cancer | Esophageal Stent StenosisNetherlands
-
Johann Wolfgang Goethe University HospitalCompletedStenosis of the Bilio-biliary Anastomosis After Orthotopic Liver TransplantationFinland, Germany, Italy
-
Yonsei UniversityUnknownColorectal CancerKorea, Republic of
-
Helsinki University Central HospitalRecruitingPancreatic Cancer | Pancreatic Duct StrictureFinland
-
Ajou University School of MedicineCompletedMalignant Distal Biliary StrictureKorea, Republic of
-
Boston Scientific CorporationCompletedChronic PancreatitisUnited States, Netherlands, Italy, Canada, Belgium, India
-
Samsung Medical CenterTaewoong Medical Co., Ltd.UnknownUreteral ObstructionKorea, Republic of
-
All India Institute of Medical Sciences, New DelhiCompleted